OIC International, Medi Mold, and Fives-AddUp Forge Strategic Alliance to Launch India’s First Advanced 3D Printing Hub for Orthopedic Implants

Visakhapatnam: In a landmark collaboration that spans three continents, OIC International (USA), Medi Mold, part of the Andhra Pradesh Medtech Zone (AMTZ) (India), and AddUp, a subsidiary of Fives Group (France) have announced a strategic partnership to establish India’s most advanced orthopedic implant manufacturing facility powered by 3D printing and precision engineering. The facility will be housed within AMTZ, India’s flagship medical device manufacturing park.

This trilateral arrangement marks a decisive step toward transforming India into a global hub for high-performance orthopedic implants while aligning with the Indian government’s “Make in India” and medical self-reliance initiatives. OIC is launching a first-of-its-kind line of implants manufactured in India using advanced additive 3D technology—designed for both domestic and global markets. Developed with proprietary technology, these implants aim to significantly reduce post-surgery recovery time while delivering cutting-edge solutions at a fraction of the cost and can be produced on a mass scale, close to the delivery points.

“This partnership reflects our commitment to making world-class orthopedic implants affordable and accessible in India,” said Shri Shetty, CEO of OIC International. “India is a key strategic market for us, and 3D printing is the platform that enables us to innovate, lower costs, and meet the country’s growing surgical needs. By manufacturing locally at AMTZ, we align with the government of India’s Make in India vision while delivering global-quality care to Indian patients.”